{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:13:39Z","timestamp":1794107619669,"version":"4.8.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":5912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1111\/j.1538-7836.2006.02146.x","type":"journal-article","created":{"date-parts":[[2006,9,14]],"date-time":"2006-09-14T10:31:50Z","timestamp":1158229910000},"page":"2103-2114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":972,"title":["Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor"],"prefix":"10.1016","volume":"4","author":[{"given":"J.E.","family":"SADLER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"BUDDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.J.","family":"EIKENBOOM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"FAVALORO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.G.H.","family":"HILL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"HOLMBERG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"INGERSLEV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"LILLICRAP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"MANNUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"MAZURIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"MEYER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.L.","family":"NICHOLS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"NISHINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.R.","family":"PEAKE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"RODEGHIERO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"SCHNEPPENHEIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.M.","family":"RUGGERI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"SRIVASTAVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"MONTGOMERY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"FEDERICI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0015","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI112129","article-title":"Substructure of human von Willebrand factor","volume":"76","author":"Fowler","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate\u2010P in von Willebrand disease","volume":"4","author":"Dobrkovska","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","article-title":"II. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis","volume":"94","author":"Menache","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0040","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0037-1616109","article-title":"Recommended abbreviations for von Willebrand factor and its activities","volume":"86","author":"Mazurier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0037-1615770","article-title":"A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor","volume":"85","author":"Goodeve","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0055","first-page":"177","article-title":"Willebrand disease: a database of point mutations, insertions, and deletions","volume":"69","author":"Ginsburg","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0038-1651577","article-title":"A database of polymorphisms in the von Willebrand factor gene and pseudogene","volume":"69","author":"Sadler","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage\u2010specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1538-7836.2006.01860.x","article-title":"Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study","volume":"4","author":"James","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0037-1613375","article-title":"Genome\u2010wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project","volume":"89","author":"Souto","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0090","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1046\/j.1538-7836.2003.00314.x","article-title":"Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci","volume":"1","author":"De Visser","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0095","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1182\/blood.V93.12.4277","article-title":"Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter","volume":"93","author":"Keightley","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2141.2000.02000.x","article-title":"A single nucleotide polymorphism at nucleotide \u20101793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels","volume":"109","author":"Harvey","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2141.2001.03089.x","article-title":"High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene","volume":"115","author":"Kamphuisen","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0110","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0115","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V98.10.2973","article-title":"Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins","volume":"98","author":"Bod\u00f3","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0037-1613232","article-title":"Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X)","volume":"88","author":"Lethagen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0130","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood.V99.11.4243","article-title":"The elusive pathogenesis of von Willebrand disease Vicenza","volume":"99","author":"Castaman","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0135","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine\u2010mutations in von Willebrand factor associated with increased clearance","volume":"3","author":"Van Schooten","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","article-title":"Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease","volume":"47","author":"Mannucci","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1661458","article-title":"Comparative study of intranasal, subcutaneous and intravenous administration of desamino\u2010d\u2010arginine vasopressin (DDAVP)","volume":"55","author":"Kohler","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0150","first-page":"128a","article-title":"A mutation in the D4 domain of von Willebrand factor (VWF) results in a variant of type 1 von Willebrand disease with accelerated in vivo VWF clearance","volume":"100","author":"Gavazova","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0155","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post\u2010DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process","volume":"1","author":"Brown","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0609.1988.tb00815.x","article-title":"Hyper\u2010responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra\u2010platelet von Willebrand factor","volume":"40","author":"Rodeghiero","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"Willebrand disease \u2018\u2018Vicenza\u2019\u2019 with larger\u2010than\u2010normal (supranormal) von Willebrand factor multimers","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1309\/75CQ-V7UX-4QX8-WXE7","article-title":"Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry","volume":"116","author":"Studt","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0180","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Willebrand factor haplotype associated with type 1 von Willebrand disease","volume":"102","author":"O'Brien","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0185","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood-2003-05-1505","article-title":"An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13","volume":"103","author":"Bowen","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0190","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2141.2005.05375.x","article-title":"The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co\u2010segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype","volume":"128","author":"Bowen","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0195","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/j.1538-7836.2005.01631.x","article-title":"Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype","volume":"3","author":"Lanke","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2141.2005.05637.x","article-title":"The Y\/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor","volume":"130","author":"Millar","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/beha.2001.0135","article-title":"Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder","volume":"14","author":"Favaloro","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","article-title":"Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE)","volume":"77","author":"Zimmerman","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0215","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"84","author":"Gaucher","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0220","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00209487","article-title":"Identification of a candidate missense mutation in a family with von Willebrand disease type IIC","volume":"95","author":"Schneppenheim","year":"1995","journal-title":"Hum Genet"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0225","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1172\/JCI110700","article-title":"Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC)","volume":"70","author":"Ruggeri","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0230","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys \u00d8 Arg mutation in type IID von Willebrand disease","volume":"93","author":"Schneppenheim","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0235","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V63.6.1369.1369","article-title":"A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII\u2010related antigen (type IID)","volume":"63","author":"Kinoshita","year":"1984","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of von Willebrand disease","volume":"14","author":"Schneppenheim","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2006.02146.x_bb0245","first-page":"P1805","article-title":"The first mutations in von Willebrand disease type IIC Miami","author":"Schneppenheim","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood.V82.1.169.bloodjournal821169","article-title":"New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami","volume":"82","author":"Ledford","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0255","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor","volume":"87","author":"Dent","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0260","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00894-004-0194-9","article-title":"Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations","volume":"10","author":"Sutherland","year":"2004","journal-title":"J Mol Model (Online)"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0270","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0275","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1\u2010desamino\u20108\u2010d\u2010arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0280","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/blood.V89.8.2766","article-title":"Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow","volume":"89","author":"Lankhof","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0285","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI115122","article-title":"Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences","volume":"87","author":"Randi","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0290","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI115123","article-title":"The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain","volume":"87","author":"Cooney","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0295","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/beha.2001.0137","article-title":"Type 2 von Willebrand disease causing defective von Willebrand factor\u2010dependent platelet function","volume":"14","author":"Meyer","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0300","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.107355","article-title":"Structures of glycoprotein Ib\u03b1 and its complex with von Willebrand factor A1 domain","volume":"297","author":"Huizinga","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0305","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"Holmberg","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0310","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(93)91070-3","article-title":"Recessive inheritance of von Willebrand's disease type I","volume":"341","author":"Eikenboom","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0315","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin\u2010induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0325","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.88.11.4761","article-title":"Mutation in the gene encoding the \u03b1 chain of platelet glycoprotein Ib in platelet\u2010type von Willebrand disease","volume":"88","author":"Miller","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0330","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V81.7.1787.1787","article-title":"Pseudo\u2010von Willebrand disease: a mutation in the platelet glycoprotein Ib\u03b1 gene associated with a hyperactive surface receptor","volume":"81","author":"Russell","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0335","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI116438","article-title":"Expression of the phenotypic abnormality of platelet\u2010type von Willebrand disease in a recombinant glycoprotein Ib\u03b1 fragment","volume":"91","author":"Murata","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0340","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2002-09-2942","article-title":"Identification and functional characterization of a novel 27\u2010bp deletion in the macroglycopeptide\u2010coding region of the GPIBA gene resulting in platelet\u2010type von Willebrand disease","volume":"105","author":"Othman","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0345","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V60.3.790.790","article-title":"Willebrand's disease: characterization of a new bleeding disorder","volume":"60","author":"Miller","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0350","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM198202113060603","article-title":"Pseudo\u2010von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII\/von Willebrand factor and enhanced adsorption of its high\u2010molecular\u2010weight multimers","volume":"306","author":"Weiss","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0355","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V66.6.1423.1423","article-title":"High\u2010resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)","volume":"66","author":"Ciavarella","year":"1985","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0360","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.89.20.9846","article-title":"Willebrand disease type B: a missense mutation selectively abolishes ristocetin\u2010induced von Willebrand factor binding to platelet glycoprotein Ib","volume":"89","author":"Rabinowitz","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0365","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0037-1616142","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0370","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0375","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease\u2010causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0380","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.2003.04163.x","article-title":"Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII\u2010binding capacity","volume":"120","author":"Hilbert","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0385","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1538-7836.2004.01049.x","article-title":"First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene","volume":"2","author":"Hilbert","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0390","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0038-1650628","article-title":"Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1","volume":"76","author":"Schneppenheim","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0395","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0400","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650567","article-title":"Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease. Results of an international survey","volume":"76","author":"Mazurier","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0405","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ajh.2830400105","article-title":"Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII","volume":"40","author":"Lopez\u2010Fernandez","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0410","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2N (\u2018Normandy\u2019) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0415","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0420","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0925-5710(96)00470-7","article-title":"Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy","volume":"64","author":"Nishino","year":"1996","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0425","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF00206958","article-title":"Genetic heterogeneity of severe von Willebrand disease type III in the German population","volume":"94","author":"Schneppenheim","year":"1994","journal-title":"Hum Genet"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0430","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF00191794","article-title":"Effects of the mutant von Willebrand factor gene in von Willebrand disease","volume":"96","author":"Zhang","year":"1995","journal-title":"Hum Genet"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0435","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V74.7.2433.2433","article-title":"Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease","volume":"74","author":"Mannucci","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0440","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0445","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0450","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood.V92.12.4663","article-title":"A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization","volume":"92","author":"Jorieux","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0455","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2002-27820","article-title":"Laboratory diagnosis of congenital von Willebrand disease","volume":"28","author":"Budde","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0460","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2516.2004.00979.x","article-title":"Willebrand disease: laboratory aspects of diagnosis and treatment","volume":"10","author":"Favaloro","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0465","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1055\/s-0037-1614188","article-title":"Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease\u2013single center comparison of four different assays","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0470","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2004.00894.x","article-title":"The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors\u2019 Organization","volume":"10","author":"Laffan","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0475","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin\u2010 but not botrocetin\u2010mediated binding of von Willebrand factor to platelets","volume":"91","author":"Hillery","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0480","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.101.13.1546","article-title":"Genetic determinants of hemostasis phenotypes in Spanish families","volume":"101","author":"Souto","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0485","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1538-7933.2003.00592.x","article-title":"Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C\u2010deficient family","volume":"2","author":"Vossen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0490","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V54.1.117.117","article-title":"Genetics of classic von Willebrand's disease. I. Phenotypic variation within families","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0495","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/s-0037-1614330","article-title":"Inconsistency of association between type 1 von Willebrand Disease phenotype and genotype in families identified in an epidemiological investigation","volume":"82","author":"Castaman","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0500","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.2001.03132.x","article-title":"Significant linkage and non\u2010linkage of type 1 von Willebrand disease to the von Willebrand factor gene","volume":"115","author":"Casa\u00f1a","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0505","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0510","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes","volume":"59","author":"Ruggeri","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0515","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00043426-200311000-00010","article-title":"Desmopressin (DDAVP) responsiveness in children with von Willebrand disease","volume":"25","author":"Revel\u2010Vilk","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0520","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's Disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0525","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0530","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM\u20101 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0535","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0540","first-page":"77","article-title":"A sensitive ristocetin co\u2010factor activity assay with recombinant glycoprotein Ib\u03b1 for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2006.02146.x_bb0545","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1160\/TH04-04-0402","article-title":"Plasma glycocalicin as a source of GPIb\u03b1 in the von Willebrand factor ristocetin cofactor ELISA","volume":"93","author":"Vanhoorelbeke","year":"2005","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.02146.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622115928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622115928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.02146.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:38:58Z","timestamp":1761532738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622115928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":108,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1538783622115928"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02146.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02146.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}